EGRX - Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript

Eagle Pharmaceuticals, Inc. (EGRX) Q4 2021 Earnings Conference Call March 07, 2022, 08:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tarriff - Founder, Chief Executive Officer, President Brian Cahill - Chief Financial Officer Conference Call Participants Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald David Amsellem - Piper Sandler Presentation Operator Good morning, everyone. My name is Ashley, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Fourth Quarter and Full Year 2021 Financial Results. All lines have been placed on mute to prevent any background noise. After the speaker's remarks there will be a question-and-answer period. [Operator instructions] As a reminder, this conference call is being recorded today, March 7th, 2022. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead. Lisa Wilson Thank

For further details see:

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript